Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Takeshi Kawakami

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9385-9516; OpenAlex author ID A5068742608, A5102401489. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer. Last author DOI 10.1002/cnr2.70485↗
  2. Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. Co-author DOI 10.1038/s10038-022-01097-y↗
  3. Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. Co-author DOI 10.1186/s12885-023-10542-w↗
  4. Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study. Co-author DOI 10.1007/s10637-022-01221-x↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kentaro Yamazaki · 3 shared papers, 2022–2023 · strength 0.47
  2. Hirofumi Yasui · 3 shared papers, 2022–2023 · strength 0.47
  3. Akiko Todaka · 3 shared papers, 2022–2023 · strength 0.47
  4. Keita P. Mori · 1 shared paper, 2026 · strength 0.32
  5. Akane Wakabayashi · 1 shared paper, 2026 · strength 0.32
  6. Sae Ohwada · 1 shared paper, 2022 · strength 0.15
  7. Hiromichi Shirasu · 1 shared paper, 2022 · strength 0.15
  8. Hiroshi Nakase · 1 shared paper, 2022 · strength 0.15
  9. Teiichi Sugiura · 1 shared paper, 2023 · strength 0.14
  10. Yoshimi Kiyozumi · 1 shared paper, 2023 · strength 0.14
  11. Fumitaka Niiya · 1 shared paper, 2023 · strength 0.14
  12. Hirotoshi Ishiwatari · 1 shared paper, 2023 · strength 0.14
  13. Hiroyuki Matsubayashi · 1 shared paper, 2023 · strength 0.14
  14. Hiroyuki Ono · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.